THE GLOBAL ORTHOPEDIC SPLINTS AND CASTS MARKET SIZE WAS VALUED AT USD 2.34 BILLION IN 2021 AND IS EXPECTED TO REACH USD 3.34 BILLION BY 2027, GROWING AT A CAGR OF 6.06%.

The Orthopedic Splints And Casts Market Size, Share, & Trends Analysis Report By

  • Product: Casts and Splints
  • Material: Synthetic Splints & Casts, and Plaster of Paris Splints & Casts
  • Body Part: Upper Body and Lower Body
  • End User: Orthotic & Orthopedic Clinics, Hospitals, and Others
  • Geography: North America, Europe, APAC, Latin America, and Middle East & Africa

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022–2027

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

292 Pages

icon-table

119 Tables

icon-chart

140 Charts

icon-region

5 Regions

icon-country

20 Countries

icon-company

27 Companies

icon-market

5 Market Segment

GLOBAL ORTHOPEDIC SPLINTS AND CASTS MARKET REPORT SCOPE

Report Attribute Details
Market Size (2027) USD 3.34 Billion
Market Size (2021) USD 2.34 Billion
CAGR (2021-2027) 6.06%
Base Year 2021
Forecast Year 2022-2027
Market Segments Product, Material, Body Part, End User, and Geography
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
KEY PLAYERS Essity Medical Solutions, 3M, Enovis, Breg, DeRoyal Industries, and Bauerfeind

The global orthopedic splints and casts market was valued at USD 2.34 billion in 2021 and is expected to reach USD 3.34 billion by 2027, growing at a CAGR of 6.06%. The market is growing steadily with the rising patient demographics and the continuous advancements in developing orthopedic splints and casts. Further, the growing number of MSDs, road accident injuries, sports injuries, and the increasing elderly population is leading to an increase in the development of splints & casts.

MARKET TRENDS AND OPPORTUNITIES

Growing Demand For 3D Printed Casts & Splints
The area of orthopedic medicine is best suited for this technology, and the current approach comes in creating orthotics, prosthetics, custom complete joint arthroplasty implants, and others. Orthopedics is one of the most speedily advancing fields in medicine. With musculoskeletal problems, new technology and treatment are developing yearly to aid patients. 3D-printed orthoses allow digital technology to enhance the patient's experience while delivering appropriate immobilization. By scanning the limb, the fit of the cast matches the patient's exact anatomy. This prevents pressure points and allows for open areas over wounds or incisions. Interestingly, a 3D cast model has been developed, incorporating a bone stimulator directly into its design.

Many emerging companies in the orthopedic splints and casts market are developing 3D-printed splints & casts. For instance, ActiveArmour, a leading global company in 3D printed casting/splinting, designs a wholly individualized and fitted splint based on the physician's specific positioning and instructions for each patient's unique needs.

Introduction of Spray-Based Form Splint
Inventions for fixing broken bones are offered to companies wishing to license and commercialize them. Dr. Army orthopedic surgeon Kevin Martin developed and tested a new approach using fast-curing foam. Polyurethane foam is sprayed directly onto the skin, eliminating the need for nasty and unsanitary cotton swabs. Medications such as antibiotics, pain relievers, and coagulants can be added to the foam. Note that fractures can be fixed without manipulation, which reduces the chance of secondary tissue damage, bleeding, and infection. This new process is also unique. Early studies show that spray foam splints offer better fracture resistance and are easier to apply than traditional splints.

The introduction of this innovative concept around orthopedic medicine in the orthopedic splints and casts market can be a game changer because of its benefits over conventional orthopedic splints and casts. The emergence of the spray-based form splint is offering leading players and start-ups to develop orthopedic splints & casts with the help of polyurethane spray in the orthopedic splints & casts.

Increasing Target Patient Population
The number of older people is expected to double by 2050 to 1.5 billion. Globally, the population aged 65 and over has risen from 6% in 1990 to 9% in 2019. Orthopedic diseases and injuries affect the musculoskeletal system. This body’s system includes muscles, bones, nerves, joints, ligaments, tendons, and other connective tissues. Chronic orthopedic disease or injury can damage these tissues or structures.

Worldwide, 1.3 million people die yearly in road accidents, 70% of which occur in developing countries. Pedestrians are involved in 65% of deaths, 35% of which are children. Twenty to 50 million people have suffered non-fatal injuries in road accidents. These non-fatal injuries lead to fractures, bone damage, or other severe orthopedic problem. Therefore, a large target patient population, such as osteoporosis, fractures, arthritis, and road accident injury, has led to splinting and casting to heal the damaged part of the body. The technological advancements in splints and casts are helping even faster to recover or heal the injured body part. Thus, the increasing prevalence of aging, musculoskeletal disorders, sports, injury, and road accident injuries has boosted the orthopedic splints and casts market.

SEGMENTATION ANALYSIS

INSIGHTS BY PRODUCT
The global orthopedic splints and casts market is segmented into Casts and splints by product segment. The casts accounted for the largest share of 61.06% globally in 2021. Casts come in many shapes and sizes, but plaster and fiberglass are the two most used types. These are effective and efficient ways to treat fractures. Moreover, the Plaster of Paris (POP) has been a trusted expert for over 75 years. The ready-to-use casts are made from the highest quality, specially woven fabrics, and the popular POP bandage or cast is Gypsona, offered by Essity Medical. The product has gained tremendous popularity in the global orthopedic splints and casts market.

The size of the orthopedic splint segment is expected to increase significantly at a CAGR of 6.37% during the forecast period due to the rapidly growing target population. The vastly increasing number of older people worldwide gives way to an increasing burden of bone fractures and musculoskeletal disorders due to age-related osteoporosis. The rise in bone diseases, trauma, road accidents, and falls significantly generate market revenue.

INSIGHTS BY MATERIAL
Synthetic splints & casts accounted for the largest share of 67.86% in the global orthopedic splints and casts market in 2021 by material type. Today, synthetic splints & casts are used more often than plaster casts. They’re usually made from fiberglass, polyester, polyethylene, nylon, and other synthetic fabric materials. Under synthetic segmentation, fiberglass splints & casts are the most significant sub-segments. The synthetic segment market growth is attributed to the various advantages of fiberglass splints & casts over other types of splints & casts.

The global orthopedic splints and casts market by plaster of Paris splints & casts was valued at USD 752.36 million in 2021. Casting materials have enhanced significantly over the years; however, POP splints & casts are still widely used and familiar to all physicians. Plaster is used after repositioning the bone because it can be well molded to the patient and support the bone more precisely. When a bone is out of position and is manipulated back into place, plaster may be used to help hold the bone in the proper place.

INSIGHTS BY BODY PART
The upper body accounted for the largest share of 53.14% in the global orthopedic splints and casts market in 2021 by body parts segment. Upper extremity disability due to MSDs is a common health problem in the general population and patients in primary care. Global and local vendors are coming up with innovative orthopedic splints and cast for upper-body injury resulting from a road accident injury, osteoporosis, elderly fall, sports injury, and other MSDs. For instance, CORFLEX GLOBAL, a leading player headquartered in the US, has vast upper limb splints and casts product portfolio such as ultra fit wrist splints, COOLTEX AG 9” wrist splints, boxer splints, XR cubital tunnel splints, hanging casts, etc.

INSIGHTS BY END USER
The orthotic & orthopedic clinics segment accounts for the highest share of 48.01% in the global orthopedic splints and casts market by end-user. The segment offers exclusive healthcare services to patients with suspected or diagnosed orthopedic diseases. These centers are merely dedicated to treating patients suffering from various orthopedic ailments like arrhythmia and structural heart diseases and offer quality care. This is due to the convenience of sophisticated infrastructure related to diagnosing and treating MSDs in standalone orthopedic centers compared to hospitals.

The global orthopedic splints & casts market by the hospital is growing at a CAGR of 5.65% during the forecast period. The growth is attributed to the fact that most patients still prefer orthopedic surgeries in hospitals rather than other healthcare settings. The hospital is the first point of contact in any road accident, injury, or fracture; people always prefer to move the injured faster into the hospital.

GEOGRAPHICAL ANALYSIS

The APAC region accounted for a share of 30.27% in the global orthopedic splints and casts market in 2021 and emerged as a leading region in the market. The increased number of MSDs incidence, a growing aging population, and related health conditions contribute to the region’s growth. APAC accommodates many regional and local orthopedic splints and cast manufacturers actively developing innovative orthopedic splints and casts at affordable costs. China, Japan, Australia, India, and South Korea are major countries contributing to the exponential growth of the market in this region. China’s population over 65 years will cover 18.2% of the total by 2030. Due to an aging society and enhancing living standards, the number of people with limb dyskinesia is increasing quickly.

The European orthopedic splints and casts market was valued at USD 636 million in 2021. The growth of this region is primarily attributed to the increasing number of orthopedic diseases and accidental injuries and the elderly population. The region is growing at a healthy rate and is expected to grow at a similar pace from 2021-2027. Germany, the UK, France, Spain, and Italy are the major revenue generators in the region.

North America accounts for a 25.95% share of the global orthopedic splints and casts market and is likely to witness an incremental growth of around USD 237.61 million during the forecast period. The growth of this region is primarily attributed to the increasing number of orthopedic diseases and accidental injuries and the elderly population. The availability of advanced braces and support developers, constant technological innovations, and growing acceptance of technologically advanced braces and supports further accelerate the region's market growth.

VENDOR LANDSCAPE

Many international, regional, and local vendors characterize the global orthopedic splints and casts market. Essity Medical Solutions, 3M, Breg, envois, DeRoyal Industries, Bauerfeind, and Tynor are the key players in the orthopedic splints and casts market. Prime Medical, Datta Mediproducts, Bird & Cronin, Performance health, DUK-IN, medi, Orthosys, and Alimed have a significant presence in respective regions and countries. Some small start-ups and regional players are also trying to compete in advanced orthopedic splints and casts. Larger healthcare companies tend to acquire, invest in, or partner with these SMEs to diversify their products and participate in digital health.

Recent Developments In The Global Orthopedic Splints And Casts Market

  • In early 2019, Enovis (formulary known as Colfax) completed the acquisition of DJO for around USD 3.15 billion. With this acquisition, Colfax aimed to create a new platform for itself in the orthopedic market, as DJO was one of the leading companies in braces and support devices.
  • Breg, a leading orthopedic and billing services company, partnered with its UK distributor, Joint Operations, to expand the supply of high-quality orthopedic products to the UK/Ireland market in July 2020.

Frequently Asked Questions

How big is the orthopedic splints and casts market?

The global orthopedic splints and casts market size was valued at USD 2.34 billion in 2021 and is expected to reach USD 3.34 billion by 2027.

What is the growth rate of the global orthopedic splints and casts market?

The global orthopedic splints and casts market share is expected to grow at a CAGR of 6.06% from 2021 to 2027.

Which region holds the most prominent global orthopedic splints and casts market share?

In 2021, APAC dominated the orthopedic splints & casts market with the highest share of around 30.27%.

Who are the key players in the orthopedic splints and casts market?

Essity Medical Solutions, 3M, Enovis, Breg, DeRoyal Industries, and Bauerfeind are the key players in the global orthopedic splints and casts market.

What are the growth opportunities in the orthopedic splints and casts market?

Growing demand for 3D printed casts & splints, availability of a wider product portfolio of splints & casts by vendors, and introduction of spray-based form splints are significant growth opportunities in the orthopedic splints & casts market.

Download Free Sample

The orthopedic splints and casts market is expected to grow at a CAGR of approximately 6.06% from 2021 to 2027.

The following factors are likely to contribute to the growth of the orthopedic splints & casts market during the forecast period:

  • Increasing Target Patient Population
  • Rising Adoption of Fiberglass Casts & Splints
  • Paradigm Shift Towards Outpatient Orthopedic Care

Base Year: 2021

Forecast Year: 2022-2027

The report considers the present scenario of the orthopedic splints & casts market and its market dynamics for 2022−2027. It covers a detailed overview of several industry growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.

Key Company Profiles

  • Essity Medical Solutions
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • 3M
  • Enovis
  • Breg
  • DeRoyal Industries
  • Bauerfeind

Other Prominent Vendors

  • ALCARE
    • Business Overview
    • Product Offerings
  • Frank Stubbs Company
  • Weber Orthopedic LP. DBA Hely & Weber
  • medi
  • Carolina Narrow Fabric
  • Thuasne Group
  • Trulife
  • Tynor
  • Orthosys
  • DUK-IN
  • Performance Health
  • AliMed
  • Lohmann & Rauscher
  • Elite Orthopaedics
  • Allard USA
  • BraceAbility
  • VISSCO REHABILITATION
  • Bird & Cronin
  • Datt Mediproducts
  • Prime Medical
  • Yunbiotech

Segmentation by Product

  • Casts
  • Splints

Segmentation by Material

  • Synthetic Splints & Casts
  • Plaster of Paris Splints & Casts

Segmentation by Body Part

  • Upper Body
  • Lower Body

Segmentation by End User

  • Orthotic & Orthopedic Clinics
  • Hospitals
  • Others

Segmentation by Geography

  • APAC
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Europe
    • Germany
    • Italy
    • Spain
    • France
    • UK
  • North America
    • US
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • South Africa
    • South Arabia
    • Egypt
    • Nigeria

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 PREMIUM INSIGHTS

7.1 MARKET OVERVIEW

7.1.1 MARKET DYNAMICS

7.1.2 MARKET SEGMENTATION

7.1.3 VENDOR ANALYSIS

8 INTRODUCTION

8.1 OVERVIEW

8.1.1 MUSCULOSKELETAL DISORDERS STATISTICS

9 MARKET OPPORTUNITIES & TRENDS

9.1 GROWING DEMAND FOR 3D-PRINTED CASTS & SPLINTS

9.2 AVAILABILITY OF WIDER PRODUCT PORTFOLIO OF SPLINTS & CASTS BY VENDOR

9.3 INTRODUCTION OF SPRAY-BASED FORM SPLINTS

10 MARKET GROWTH ENABLERS

10.1 INCREASING TARGET PATIENT POPULATION

10.2 RISING ADOPTION OF FIBERGLASS CASTS & SPLINTS

10.3 PARADIGM SHIFT TOWARD OUTPATIENT ORTHOPEDIC CARE

11 MARKET RESTRAINTS

11.1 COMPLICATIONS ASSOCIATED WITH THE USE OF SPLINTS AND CASTS

11.2ALTERNATIVE TREATMENT OPTIONS FOR ORTHOPEDIC DISORDERS & CONDITIONS

11.3 LACK OF PRODUCT DIFFERENTIATION COUPLED WITH PRICING PRESSURE

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW

12.2 MARKET SIZE & FORECAST

12.2.1 INSIGHT BY PRODUCT SEGMENTATION

12.2.2 INSIGHT BY MATERIAL SEGMENTATION

12.2.3 INSIGHT BY BODY PART SEGMENTATION

12.2.4 INSIGHT BY END-USERS SEGMENTATION

12.2.5 INSIGHT BY GEOGRAPHY SEGMENTATION

12.3 FIVE FORCES ANALYSIS

12.3.1 THREAT OF NEW ENTRANTS

12.3.2 BARGAINING POWER OF SUPPLIERS

12.3.3 BARGAINING POWER OF BUYERS

12.3.4 THREAT OF SUBSTITUTES

12.3.5 COMPETITIVE RIVALRY

13 PRODUCT

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 CASTS

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 MARKET BY GEOGRAPHY

13.4 SPLINT

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 MARKET BY GEOGRAPHY

14 MATERIALS

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 SYNTHETIC SPLINTS & CASTS

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 MARKET BY GEOGRAPHY

14.4 PLASTER OF PARIS SPLINTS & CASTS

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 MARKET BY GEOGRAPHY

15 BODY PART

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 UPPER BODY

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.3.3 MARKET BY GEOGRAPHY

15.4 LOWER BODY

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.4.3 MARKET BY GEOGRAPHY

16 END-USER

16.1 MARKET SNAPSHOT & GROWTH ENGINE

16.2 MARKET OVERVIEW

16.3 ORTHOTIC & ORTHOPEDIC CLINICS

16.3.1 MARKET OVERVIEW

16.3.2 MARKET SIZE & FORECAST

16.3.3 MARKET BY GEOGRAPHY

16.4 HOSPITAL

16.4.1 MARKET OVERVIEW

16.4.2 MARKET SIZE & FORECAST

16.4.3 MARKET BY GEOGRAPHY

16.5 OTHERS

16.5.1 MARKET OVERVIEW

16.5.2 MARKET SIZE & FORECAST

16.5.3 MARKET BY GEOGRAPHY

17 GEOGRAPHY

17.1 MARKET SNAPSHOT & GROWTH ENGINE

17.2 GEOGRAPHIC OVERVIEW

18 APAC

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.3 APAC: PRODUCT SEGMENTATION

18.4 APAC: MATERIAL SEGMENTATION

18.5 APAC: BODY PART SEGMENTATION

18.6 APAC: END USER SEGMENTATION

18.7 KEY COUNTRIES

18.7.1 CHINA: MARKET SIZE & FORECAST

18.7.2 INDIA: MARKET SIZE & FORECAST

18.7.3 JAPAN: MARKET SIZE & FORECAST

18.7.4 SOUTH KOREA: MARKET SIZE & FORECAST

18.7.5 AUSTRALIA: MARKET SIZE & FORECAST

19 EUROPE

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.3 EUROPE: PRODUCT SEGMENTATION

19.4 EUROPE: MATERIAL SEGMENTATION

19.5 EUROPE: BODY PART SEGMENTATION

19.6 EUROPE: END-USER SEGMENTATION

19.7 KEY COUNTRIES

19.7.1 GERMANY: MARKET SIZE & FORECAST

19.7.2 FRANCE: MARKET SIZE & FORECAST

19.7.3 THE UK: MARKET SIZE & FORECAST

19.7.4 ITALY: MARKET SIZE & FORECAST

19.7.5 SPAIN: MARKET SIZE & FORECAST

20 NORTH AMERICA

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.3 NORTH AMERICA: PRODUCT SEGMENTATION

20.4 NORTH AMERICA: MATERIAL SEGMENTATION

20.5 NORTH AMERICA: BODY PART SEGMENTATION

20.6 NORTH AMERICA: END-USER SEGMENTATION

20.7 KEY COUNTRIES

20.7.1 US: MARKET SIZE & FORECAST

20.7.2 CANADA: MARKET SIZE & FORECAST

21 LATIN AMERICA

21.1 MARKET OVERVIEW

21.2 MARKET SIZE & FORECAST

21.3 LATIN AMERICA: PRODUCT SEGMENTATION

21.4 LATIN AMERICA: MATERIAL SEGMENTATION

21.5 LATIN AMERICA: BODY PART SEGMENTATION

21.6 LATIN AMERICA: END-USER SEGMENTATION

21.7 KEY COUNTRIES

21.7.1 BRAZIL: MARKET SIZE & FORECAST

21.7.2 MEXICO: MARKET SIZE & FORECAST

21.7.3 ARGENTINA: MARKET SIZE & FORECASTS

22 MIDDLE EAST & AFRICA

22.1 MARKET OVERVIEW

22.2 MARKET SIZE & FORECAST

22.3 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION

22.4 MIDDLE EAST & AFRICA: MATERIAL SEGMENTATION

22.5 MIDDLE EAST & AFRICA: BODY PART SEGMENTATION

22.6 MIDDLE EAST & AFRICA: END-USER SEGMENTATION

22.7 KEY COUNTRIES

22.7.1 TURKEY: MARKET SIZE & FORECAST

22.7.2 SOUTH AFRICA: MARKET SIZE & FORECAST

22.7.3 SAUDI ARABIA: MARKET SIZE & FORECAST

22.7.4 EGYPT: MARKET SIZE & FORECAST

22.7.5 NIGERIA: MARKET SIZE & FORECAST

23 COMPETITIVE LANDSCAPE

23.1 COMPETITION OVERVIEW

23.2 MARKET SHARE ANALYSIS

24 KEY COMPANY PROFILES

24.1 ESSITY MEDICAL SOLUTIONS

24.1.1 BUSINESS OVERVIEW

24.1.2 ESSITY MEDICAL SOLUTIONS IN ORTHOPEDIC SPLINTS & CASTS MARKET

24.1.3 PRODUCT OFFERINGS

24.1.4 KEY STRATEGIES

24.1.5 KEY STRENGTHS

24.1.6 KEY OPPORTUNITIES

24.2 3M

24.2.1 BUSINESS OVERVIEW

24.2.2 3M IN ORTHOPEDIC SPLINTS & CASTS MARKET

24.2.3 PRODUCT OFFERINGS

24.2.4 KEY STRATEGIES

24.2.5 KEY STRENGTHS

24.2.6 KEY OPPORTUNITIES

24.3 ENVOIS

24.3.1 BUSINESS OVERVIEW

24.3.2 ENOVIS IN ORTHOPEDIC SPLINTS & CASTS MARKET

24.3.3 PRODUCT OFFERINGS

24.3.4 KEY STRATEGIES

24.3.5 KEY STRENGTHS

24.3.6 KEY OPPORTUNITIES

24.4 BREG

24.4.1 BUSINESS OVERVIEW

24.4.2 BREG IN ORTHOPEDIC SPLINTS & CASTS MARKET

24.4.3 PRODUCT OFFERINGS

24.4.4 KEY STRATEGIES

24.4.5 KEY STRENGTHS

24.4.6 KEY OPPORTUNITIES

24.5 DEROYAL INDUSTRIES

24.5.1 BUSINESS OVERVIEW

24.5.2 DEROYAL INDUSTRIES IN ORTHOPEDIC SPLINTS & CASTS MARKET

24.5.3 PRODUCT OFFERINGS

24.5.4 KEY STRATEGIES

24.5.5 KEY STRENGTHS

24.5.6 KEY OPPORTUNITIES

24.6 BAUERFEIND

24.6.1 BUSINESS OVERVIEW

24.6.2 BAUERFEIND IN ORTHOPEDIC SPLINTS & CASTS MARKET

24.6.3 PRODUCT OFFERINGS

24.6.4 KEY STRATEGIES

24.6.5 KEY STRENGTHS

24.6.6 KEY OPPORTUNITIES

25 OTHER PROMINENT VENDORS

25.1 ALCARE

25.1.1 BUSINESS OVERVIEW

25.1.2 PRODUCT OFFERINGS

25.2 FRANK STUBBS COMPANY

25.2.1 BUSINESS OVERVIEW

25.2.2 PRODUCT OFFERINGS

25.3 WEBER ORTHOPEDIC LP. DBA HELY & WEBER

25.3.1 BUSINESS OVERVIEW

25.3.2 PRODUCT OFFERINGS

25.4 MEDI

25.4.1 BUSINESS OVERVIEW

25.4.2 PRODUCT OFFERINGS

25.5 CAROLINA NARROW FABRIC

25.5.1 BUSINESS OVERVIEW

25.5.2 PRODUCT OFFERINGS

25.6 THUASNE GROUP

25.6.1 BUSINESS OVERVIEW

25.6.2 PRODUCT OFFERINGS

25.7 TRULIFE

25.7.1 BUSINESS OVERVIEW

25.7.2 PRODUCT OFFERINGS

25.8 TYNOR

25.8.1 BUSINESS OVERVIEW

25.8.2 PRODUCT OFFERINGS

25.9 ORTHOSYS

25.9.1 BUSINESS OVERVIEW

25.9.2 PRODUCT OFFERINGS

25.10 DUK-IN

25.10.1 BUSINESS OVERVIEW

25.10.2 PRODUCT OFFERINGS

25.11 PERFORMANCE HEALTH

25.11.1 BUSINESS OVERVIEW

25.11.2 PRODUCT OFFERINGS

25.12 ALIMED

25.12.1 BUSINESS OVERVIEW

25.12.2 PRODUCT OFFERINGS

25.13 LOHMANN & RAUSCHER

25.13.1 BUSINESS OVERVIEW

25.13.2 PRODUCT OFFERINGS

25.14 ELITE ORTHOPAEDICS

25.14.1 BUSINESS OVERVIEW

25.14.2 PRODUCT OFFERINGS

25.15 ALLARD USA

25.15.1 BUSINESS OVERVIEW

25.15.2 PRODUCT OFFERINGS

25.16 BRACEABILITY

25.16.1 BUSINESS OVERVIEW

25.16.2 PRODUCT OFFERINGS

25.17 VISSCO REHABILITATION AIDS

25.17.1 BUSINESS OVERVIEW

25.17.2 PRODUCT OFFERINGS

25.18 BIRD & CRONIN

25.18.1 BUSINESS OVERVIEW

25.18.2 PRODUCT OFFERINGS

25.19 DATT MEDIPRODUCTS

25.19.1 BUSINESS OVERVIEW

25.19.2 PRODUCT OFFERINGS

25.20 PRIME MEDICAL

25.20.1 BUSINESS OVERVIEW

25.20.2 PRODUCT OFFERINGS

26 REPORT SUMMARY

26.1 KEY TAKEAWAYS

26.2 STRATEGIC RECOMMENDATIONS

27 QUANTITATIVE SUMMARY

27.1 MARKET BY PRODUCT

27.1.1 APAC: PRODUCT SEGMENTATION

27.1.2 EUROPE: PRODUCT SEGMENTATION

27.1.3 NORTH AMERICA: PRODUCT SEGMENTATION

27.1.4 LATIN AMERICA: PRODUCT SEGMENTATION

27.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION

27.2 MARKET BY MATERIAL

27.2.1 APAC: MATERIAL SEGMENTATION

27.2.2 EUROPE: MATERIAL SEGMENTATION

27.2.3 NORTH AMERICA: MATERIAL SEGMENTATION

27.2.4 LATIN AMERICA: MATERIAL SEGMENTATION

27.2.5 MIDDLE EAST & AFRICA: MATERIAL SEGMENTATION

27.3 MARKET BY BODY PART

27.3.1 APAC: BODY PART SEGMENTATION

27.3.2 EUROPE: BODY PART SEGMENTATION

27.3.3 NORTH AMERICA: BODY PART SEGMENTATION

27.3.4 LATIN AMERICA: BODY PART SEGMENTATION

27.3.5 MIDDLE EAST & AFRICA: BODY PART SEGMENTATION

27.4 MARKET BY END-USERS

27.4.1 APAC: END USER SEGMENTATION

27.4.2 EUROPE: END USER SEGMENTATION

27.4.3 NORTH AMERICA: END USER SEGMENTATION

27.4.4 LATIN AMERICA: END USER SEGMENTATION

27.4.5 MIDDLE EAST & AFRICA: END USER SEGMENTATION

27.5 GEOGRAPHY SEGMENTATION

27.5.1 CASTS: GEOGRAPHY SEGMENTATION

27.5.2 SPLINTS: GEOGRAPHY SEGMENTATION

27.5.3 SYNTHETIC SPLINTS & CASTS: GEOGRAPHY SEGMENTATION

27.5.4 PLASTER OF PARIS SPLINTS & CASTS: GEOGRAPHY SEGMENTATION

27.5.5 UPPER BODY: GEOGRAPHY SEGMENTATION

27.5.6 LOWER BODY: GEOGRAPHY SEGMENTATION

27.5.7 ORTHOTIC & ORTHOPEDIC CLINICS: GEOGRAPHY SEGMENTATION

27.5.8 HOSPITALS: GEOGRAPHY SEGMENTATION

27.5.9 OTHERS: GEOGRAPHY SEGMENTATION

28 APPENDIX

28.1 ABBREVIATIONS

LIST OF EXHIBITS

EXHIBIT 1 SEGMENTATION OF THE GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021

EXHIBIT 3 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET 2021-2027 ($ MILLION)

EXHIBIT 4 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET: SEGMENTATION

EXHIBIT 5 IMPACT OF GROWING DEMAND FOR 3D PRINTED CASTS & SPLINTS

EXHIBIT 6 BENEFITS OF 3D PRINTED SPLINTS AND CASTS

EXHIBIT 7 IMPACT OF AVAILABILITY OF WIDER PRODUCT PORTFOLIO OF SPLINTS & CASTS BY VENDOR

EXHIBIT 8 IMPACT OF INTRODUCTION OF SPRAY-BASED FORM SPLINTS

EXHIBIT 9 IMPACT OF INCREASING TARGET PATIENT POPULATION

EXHIBIT 10 IMPACT OF RISING ADOPTION OF FIBERGLASS CASTS & SPLINTS

EXHIBIT 11 IMPACT OF PARADIGM SHIFT TOWARD OUTPATIENT ORTHOPEDIC CARE

EXHIBIT 12 SHIFT TO OUTPATIENT CARE FOR ORTHOPEDIC SURGERY IN US

EXHIBIT 13 COMMON TYPES OF AMBULATORY SURGICAL PROCEDURES

EXHIBIT 14 IMPACT OF COMPLICATIONS ASSOCIATED WITH USE OF SPLINTS AND CASTS

EXHIBIT 15 IMPACT OF ALTERNATIVE TREATMENT OPTIONS FOR ORTHOPEDIC DISORDERS & CONDITIONS

EXHIBIT 16 ALTERNATIVE APPROACH TOWARD ORTHOPEDIC DISORDERS AND CONDITIONS

EXHIBIT 17 IMPACT OF LACK OF PRODUCT DIFFERENTIATION COUPLED WITH PRICING PRESSURE

EXHIBIT 18 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET 2021–2027 ($ MILLION)

EXHIBIT 19 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY PRODUCT SEGMENTATION: MARKET SHARE 2021 & 2027

EXHIBIT 20 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY MATERIAL SEGMENTATION: MARKET SHARE 2021 & 2027

EXHIBIT 21 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY BODY PART SEGMENTATION: MARKET SHARE 2021 & 2027

EXHIBIT 22 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY END-USERS SEGMENTATION: MARKET SHARE 2021 & 2027

EXHIBIT 23 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY GEOGRAPHY SEGMENTATION: MARKET SHARE 2021 & 2027

EXHIBIT 24 FIVE FORCES ANALYSIS 2021

EXHIBIT 25 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 26 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY PRODUCT

EXHIBIT 27 OVERVIEW OF ORTHOPEDIC SPLINTS & CASTS MARKET

EXHIBIT 28 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY PRODUCT: INCREMENTAL GROWTH

EXHIBIT 29 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY PRODUCT: ABSOLUTE GROWTH

EXHIBIT 30 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY CASTS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 31 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET 2021–2027 ($ MILLION)

EXHIBIT 32 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY SPLINT: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 33 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET 2021–2027 ($ MILLION)

EXHIBIT 34 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027

EXHIBIT 35 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY MATERIALS

EXHIBIT 36 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY MATERIAL: INCREMENTAL GROWTH

EXHIBIT 37 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY MATERIAL: ABSOLUTE GROWTH

EXHIBIT 38 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY SYNTHETIC: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 39 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY SYNTHETIC SPLINTS & CASTS 2021–2027 ($ MILLION)

EXHIBIT 40 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY PLASTER OF PARIS SPLINTS & CASTS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 41 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY PLASTER OF PARIS SPLINTS & CASTS 2021–2027 ($ MILLION)

EXHIBIT 42 INCREMENTAL GROWTH BY BODY PART 2021 & 2027

EXHIBIT 43 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY BODY PART

EXHIBIT 44 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY MATERIAL: INCREMENTAL GROWTH

EXHIBIT 45 SYMPTOMS RELATED TO LIMB INJURIES

EXHIBIT 46 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY BODY PART: ABSOLUTE GROWTH

EXHIBIT 47 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY UPPER BODY: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 48 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY UPPER BODY 2021–2027 ($ MILLION)

EXHIBIT 49 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY LOWER BODY: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 50 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY LOWER BODY 2021–2027 ($ MILLION)

EXHIBIT 51 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 52 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY END-USER

EXHIBIT 53 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY END-USER: INCREMENTAL GROWTH

EXHIBIT 54 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY END-USER: ABSOLUTE GROWTH

EXHIBIT 55 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY ORTHOTIC & ORTHOPEDIC CLINICS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 56 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY ORTHOTIC & ORTHOPEDIC CLINICS 2021–2027 ($ MILLION)

EXHIBIT 57 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY HOSPITALS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 58 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY HOSPITAL 2021–2027 ($ MILLION)

EXHIBIT 59 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 60 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY OTHERS 2021–2027 ($ MILLION)

EXHIBIT 61 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 62 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY GEOGRAPHY

EXHIBIT 63 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET: KEY COUNTRIES ($ MILLION)

EXHIBIT 64 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH

EXHIBIT 65 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY END-USER: ABSOLUTE GROWTH

EXHIBIT 66 APAC ORTHOPEDIC SPLINTS & CASTS MARKET: KEY COUNTRIES

EXHIBIT 67 APAC ORTHOPEDIC SPLINTS & CASTS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 68 ORTHOPEDIC SPLINTS & CASTS MARKET IN APAC 2021–2027 ($ MILLION)

EXHIBIT 69 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 70 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027

EXHIBIT 71 INCREMENTAL GROWTH BY BODY PART 2021 & 2027

EXHIBIT 72 INCREMENTAL GROWTH BY END-USERS 2021 & 2027

EXHIBIT 73 INCREMENTAL GROWTH IN APAC 2021 & 2027

EXHIBIT 74 ORTHOPEDIC SPLINTS & CASTS MARKET IN CHINA 2021–2027 ($ MILLION)

EXHIBIT 75 ORTHOPEDIC SPLINTS & CASTS MARKET IN INDIA 2021–2027 ($ MILLION)

EXHIBIT 76 ORTHOPEDIC SPLINTS & CASTS MARKET IN JAPAN 2021–2027 ($ MILLION)

EXHIBIT 77 ORTHOPEDIC SPLINTS & CASTS MARKET IN SOUTH KOREA 2021–2027 ($ MILLION)

EXHIBIT 78 ORTHOPEDIC SPLINTS & CASTS MARKET IN AUSTRALIA 2021–2027 ($ MILLION)

EXHIBIT 79 EUROPE ORTHOPEDIC SPLINTS & CASTS MARKET: KEY COUNTRIES

EXHIBIT 80 EUROPE ROAD ACCIDENT INJURY STATISTICS 2019

EXHIBIT 81 EUROPE ORTHOPEDIC SPLINTS & CASTS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 82 ORTHOPEDIC SPLINTS & CASTS MARKET IN EUROPE 2021–2027 ($ MILLION)

EXHIBIT 83 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 84 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027

EXHIBIT 85 INCREMENTAL GROWTH BY BODY PART 2021 & 2027

EXHIBIT 86 INCREMENTAL GROWTH BY END-USERS 2021 & 2027

EXHIBIT 87 INCREMENTAL GROWTH IN EUROPE 2021 & 2027

EXHIBIT 88 ORTHOPEDIC SPLINTS & CASTS MARKET IN GERMANY 2021–2027 ($ MILLION)

EXHIBIT 89 ORTHOPEDIC SPLINTS & CASTS MARKET IN FRANCE 2021–2027 ($ MILLION)

EXHIBIT 90 ROAD ACCIDENT INJURY & ELDERLY FALL STATISTICS OF UK 2021

EXHIBIT 91 ORTHOPEDIC SPLINTS & CASTS MARKET IN UK 2021–2027 ($ MILLION)

EXHIBIT 92 ORTHOPEDIC SPLINTS & CASTS MARKET IN ITALY 2021–2027 ($ MILLION)

EXHIBIT 93 NUMBER OF FRAGILITY FRACTURES IN SPAIN

EXHIBIT 94 ORTHOPEDIC SPLINTS & CASTS MARKET IN SPAIN 2021–2027 ($ MILLION)

EXHIBIT 95 MUSCULOSKELETAL INJURY & FRACTURES STATISTICS IN US

EXHIBIT 96 NORTH AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET: KEY COUNTRIES

EXHIBIT 97 NORTH AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 98 ORTHOPEDIC SPLINTS & CASTS MARKET IN NORTH AMERICA 2021–2027 ($ MILLION)

EXHIBIT 99 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 100 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027

EXHIBIT 101 INCREMENTAL GROWTH BY BODY PART 2021 & 2027

EXHIBIT 102 INCREMENTAL GROWTH BY END-USERS 2021 & 2027

EXHIBIT 103 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027

EXHIBIT 104 ROAD ACCIDENT STATISTICS IN US

EXHIBIT 105 ORTHOPEDIC SPLINTS & CASTS MARKET IN US 2021–2027 ($ MILLION)

EXHIBIT 106 ROAD ACCIDENT INJURY & ELDERLY FALL STATISTICS OF CANADA

EXHIBIT 107 ORTHOPEDIC SPLINTS & CASTS MARKET IN CANADA 2021–2027 ($ MILLION)

EXHIBIT 108 LATIN AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET: KEY COUNTRIES

EXHIBIT 109 LATIN AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 110 ORTHOPEDIC SPLINTS & CASTS MARKET IN LATIN AMERICA 2021–2027 ($ MILLION)

EXHIBIT 111 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 112 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027

EXHIBIT 113 INCREMENTAL GROWTH BY BODY PART 2021 & 2027

EXHIBIT 114 INCREMENTAL GROWTH BY END-USERS 2021 & 2027

EXHIBIT 115 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027

EXHIBIT 116 ORTHOPEDIC SPLINTS & CASTS MARKET IN BRAZIL 2021–2027 ($ MILLION)

EXHIBIT 117 ORTHOPEDIC SPLINTS & CASTS MARKET IN MEXICO 2021–2027 ($ MILLION)

EXHIBIT 118 ORTHOPEDIC SPLINTS & CASTS MARKET IN ARGENTINA 2021–2027 ($ MILLION)

EXHIBIT 119 MIDDLE EAST & AFRICA ORTHOPEDIC SPLINTS & CASTS MARKET: KEY COUNTRIES

EXHIBIT 120 MIDDLE EAST & AFRICA ORTHOPEDIC SPLINTS & CASTS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 121 ORTHOPEDIC SPLINTS & CASTS MARKET IN MIDDLE EAST & AFRICA 2021–2027 ($ MILLION)

EXHIBIT 122 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 123 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027

EXHIBIT 124 INCREMENTAL GROWTH BY BODY PART 2021 & 2027

EXHIBIT 125 INCREMENTAL GROWTH BY END-USERS 2021 & 2027

EXHIBIT 126 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027

EXHIBIT 127 ORTHOPEDIC SPLINTS & CASTS MARKET IN TURKEY 2021–2027 ($ MILLION)

EXHIBIT 128 COSTS OF ROAD CRASHES 2017

EXHIBIT 129 ORTHOPEDIC SPLINTS & CASTS MARKET IN SOUTH AFRICA 2021–2027 ($ MILLION)

EXHIBIT 130 ORTHOPEDIC SPLINTS & CASTS MARKET IN SAUDI ARABIA 2021–2027 ($ MILLION)

EXHIBIT 131 ORTHOPEDIC SPLINTS & CASTS MARKET IN EGYPT 2021–2027 ($ MILLION)

EXHIBIT 132 ORTHOPEDIC SPLINTS & CASTS MARKET IN NIGERIA 2021–2027 ($ MILLION)

EXHIBIT 133 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET: VENDORS CAPABILITY & STRENGTHS ASSESSMENT

EXHIBIT 134 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET: KEY VENDORS MARKET DOMINANCE ANALYSIS

EXHIBIT 135 ESSITY MEDICAL SOLUTIONS: REVENUE SHARE BY BUSINESS SEGMENT (%)

EXHIBIT 136 ESSITY MEDICAL SOLUTIONS: REVENUE SHARE BY GEOGRAPHY (%)

EXHIBIT 137 3M: TOTAL REVENUE 2019-2021 ($ BILLION)

EXHIBIT 138 3M: REVENUE SHARE BY BUSINESS SEGMENT (%)

EXHIBIT 139 ENOVIS: TOTAL ANNUAL REVENUE ($ MILLION)

EXHIBIT 140 ENOVIS: REVENUE SHARE BY BUSINESS SEGMENT (%)

 

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015−2021

TABLE 3 MAJOR VENDORS SPLINTS & CASTS PORTFOLIO BY MATERIAL TYPE

TABLE 4 SOME POPULAR AVAILABLE FIBERGLASS SPLINTS & CASTS

TABLE 5 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY CASTS 2021−2027 ($ MILLION)

TABLE 6 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY CASTS 2021−2027 (%)

TABLE 7 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY SPLINT 2021−2027 ($ MILLION)

TABLE 8 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY SPLINT 2021−2027 (%)

TABLE 9 SOME POPULAR AVAILABLE SYNTHETIC SPLINTS & CASTS

TABLE 10 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY SYNTHETIC SPLINTS & CASTS 2021−2027 ($ MILLION)

TABLE 11 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY SYNTHETIC SPLINTS & CASTS 2021−2027 (%)

TABLE 12 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY PLASTER OF PARIS SPLINTS & CASTS 2021−2027 ($ MILLION)

TABLE 13 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY PLASTER OF PARIS SPLINTS & CASTS 2021−2027 (%)

TABLE 14 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY UPPER BODY 2021−2027 ($ MILLION)

TABLE 15 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY UPPER BODY 2021−2027 (%)

TABLE 16 POPULAR AVAILABLE LOWER EXTREMITY ORTHOPEDIC SPLINTS & CASTS

TABLE 17 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY LOWER BODY 2021−2027 ($ MILLION)

TABLE 18 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY LOWER BODY 2021−2027 (%)

TABLE 19 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY ORTHOTIC & ORTHOPEDIC CLINICS 2021−2027 ($ MILLION)

TABLE 20 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY ORTHOTIC & ORTHOPEDIC CLINICS 2021−2027 (%)

TABLE 21 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY HOSPITAL 2021−2027 ($ MILLION)

TABLE 22 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY HOSPITAL 2021−2027 (%)

TABLE 23 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY OTHERS 2021−2027 ($ MILLION)

TABLE 24 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY OTHERS 2021−2027 (%)

TABLE 25 ESTIMATED NUMBER OF FRACTURES AMONG ADULTS AGED 50-89 YEARS IN TURKEY

TABLE 26 ESSITY MEDICAL SOLUTIONS: MAJOR PRODUCT OFFERINGS

TABLE 27 3M: MAJOR PRODUCT OFFERINGS

TABLE 28 ENOVIS: MAJOR PRODUCT OFFERINGS

TABLE 29 BREG: MAJOR PRODUCT OFFERINGS

TABLE 30 DEROYAL INDUSTRIES’: MAJOR PRODUCT OFFERINGS

TABLE 31 BAUERFEIND: MAJOR PRODUCT OFFERINGS

TABLE 32 ALCARE: MAJOR PRODUCT OFFERINGS

TABLE 33 FRANK STUBBS COMPANY: MAJOR PRODUCT OFFERINGS

TABLE 34 WEBER ORTHOPEDIC LP. DBA HELY & WEBER: MAJOR PRODUCT OFFERINGS

TABLE 35 MEDI: MAJOR PRODUCT OFFERINGS

TABLE 36 CAROLINA NARROW FABRIC: MAJOR PRODUCT OFFERINGS

TABLE 37 THUASNE GROUP: MAJOR PRODUCT OFFERINGS

TABLE 38 TRULIFE: MAJOR PRODUCT OFFERINGS

TABLE 39 TYNOR: MAJOR PRODUCT OFFERINGS

TABLE 40 ORTHOSYS: MAJOR PRODUCT OFFERINGS

TABLE 41 DUK-IN: MAJOR PRODUCT OFFERINGS

TABLE 42 PERFORMANCE HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 43 ALIMED: MAJOR PRODUCT OFFERINGS

TABLE 44 LOHMANN & RAUSCHER: MAJOR PRODUCT OFFERINGS

TABLE 45 ELITE ORTHOPEDICS: MAJOR PRODUCT OFFERINGS

TABLE 46 ALLARD USA: MAJOR PRODUCT OFFERINGS

TABLE 47 BRACEABILITY: MAJOR PRODUCT OFFERINGS

TABLE 48 VISSCO REHABILITATION: MAJOR PRODUCT OFFERINGS

TABLE 49 BIRD & CRONIN: MAJOR PRODUCT OFFERINGS

TABLE 50 DATT MEDIPRODUCTS: MAJOR PRODUCT OFFERINGS

TABLE 51 PRIME MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 52 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY PRODUCT 2021−2027 ($ MILLION)

TABLE 53 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY PRODUCT 2021−2027 (%)

TABLE 54 APAC ORTHOPEDIC SPLINTS & CASTS MARKET BY PRODUCT 2021−2027 ($ MILLION)

TABLE 55 APAC ORTHOPEDIC SPLINTS & CASTS MARKET BY PRODUCT 2021−2027 (%)

TABLE 56 EUROPE ORTHOPEDIC SPLINTS & CASTS MARKET BY PRODUCT 2021−2027 ($ MILLION)

TABLE 57 EUROPE ORTHOPEDIC SPLINTS & CASTS MARKET BY PRODUCT 2021−2027 (%)

TABLE 58 NORTH AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET BY PRODUCT 2021−2027 ($ MILLION)

TABLE 59 NORTH AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET BY PRODUCT 2021−2027 (%)

TABLE 60 LATIN AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET BY PRODUCT 2021−2027 ($ MILLION)

TABLE 61 LATIN AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET BY PRODUCT 2021−2027 (%)

TABLE 62 MIDDLE EAST & AFRICA ORTHOPEDIC SPLINTS & CASTS MARKET BY PRODUCT 2021−2027 ($ MILLION)

TABLE 63 MIDDLE EAST & AFRICA ORTHOPEDIC SPLINTS & CASTS MARKET BY PRODUCT 2021−2027 (%)

TABLE 64 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY MATERIAL 2021−2027 ($ MILLION)

TABLE 65 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY MATERIAL 2021−2027 (%)

TABLE 66 APAC ORTHOPEDIC SPLINTS & CASTS MARKET BY MATERIAL 2021−2027 ($ MILLION)

TABLE 67 APAC ORTHOPEDIC SPLINTS & CASTS MARKET BY MATERIAL 2021−2027 (%)

TABLE 68 EUROPE ORTHOPEDIC SPLINTS & CASTS MARKET BY MATERIAL 2021−2027 ($ MILLION)

TABLE 69 EUROPE ORTHOPEDIC SPLINTS & CASTS MARKET BY MATERIAL 2021−2027 (%)

TABLE 70 NORTH AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET BY MATERIAL 2021−2027 ($ MILLION)

TABLE 71 NORTH AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET BY MATERIAL 2021−2027 (%)

TABLE 72 LATIN AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET BY MATERIAL 2021−2027 ($ MILLION)

TABLE 73 LATIN AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET BY MATERIAL 2021−2027 (%)

TABLE 74 MIDDLE EAST & AFRICA ORTHOPEDIC SPLINTS & CASTS MARKET BY MATERIAL 2021−2027 ($ MILLION)

TABLE 75 MIDDLE EAST & AFRICA ORTHOPEDIC SPLINTS & CASTS MARKET BY MATERIAL 2021−2027 (%)

TABLE 76 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY BODY PART 2021−2027 ($ MILLION)

TABLE 77 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY BODY PART 2021−2027 (%)

TABLE 78 APAC ORTHOPEDIC SPLINTS & CASTS MARKET BY BODY PART 2021−2027 ($ MILLION)

TABLE 79 APAC ORTHOPEDIC SPLINTS & CASTS MARKET BY BODY PART 2021−2027 (%)

TABLE 80 EUROPE ORTHOPEDIC SPLINTS & CASTS MARKET BY BODY PART 2021−2027 ($ MILLION)

TABLE 81 EUROPE ORTHOPEDIC SPLINTS & CASTS MARKET BY BODY PART 2021−2027 (%)

TABLE 82 NORTH AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET BY BODY PART 2021−2027 ($ MILLION)

TABLE 83 NORTH AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET BY BODY PART 2021−2027 (%)

TABLE 84 LATIN AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET BY BODY PART 2021−2027 ($ MILLION)

TABLE 85 LATIN AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET BY BODY PART 2021−2027 (%)

TABLE 86 MIDDLE EAST & AFRICA ORTHOPEDIC SPLINTS & CASTS MARKET BY BODY PART 2021−2027 ($ MILLION)

TABLE 87 MIDDLE EAST & AFRICA ORTHOPEDIC SPLINTS & CASTS MARKET BY BODY PART 2021−2027 (%)

TABLE 88 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY END-USER 2021−2027 ($ MILLION)

TABLE 89 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY END USER 2021−2027 (%)

TABLE 90 APAC ORTHOPEDIC SPLINTS & CASTS MARKET BY END-USER 2021−2027 ($ MILLION)

TABLE 91 APAC ORTHOPEDIC SPLINTS & CASTS MARKET BY END-USER 2021−2027 (%)

TABLE 92 EUROPE ORTHOPEDIC SPLINTS & CASTS MARKET BY END USER 2021−2027 ($ MILLION)

TABLE 93 EUROPE ORTHOPEDIC SPLINTS & CASTS MARKET BY END USER 2021−2027 (%)

TABLE 94 NORTH AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET BY END-USER 2021−2027 ($ MILLION)

TABLE 95 NORTH AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET BY END-USER 2021−2027 (%)

TABLE 96 LATIN AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET BY END-USER 2021−2027 ($ MILLION)

TABLE 97 LATIN AMERICA ORTHOPEDIC SPLINTS & CASTS MARKET BY END-USER 2021−2027 (%)

TABLE 98 MIDDLE EAST & AFRICA ORTHOPEDIC SPLINTS & CASTS MARKET BY END-USER 2021−2027 ($ MILLION)

TABLE 99 MIDDLE EAST & AFRICA ORTHOPEDIC SPLINTS & CASTS MARKET BY END-USER 2021−2027 (%)

TABLE 100 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY 2021−2027 ($ MILLION)

TABLE 101 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY 2021−2027 (%)

TABLE 102 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY CASTS 2021−2027 ($ MILLION)

TABLE 103 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY CASTS 2021−2027 (%)

TABLE 104 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY SPLINTS 2021−2027 ($ MILLION)

TABLE 105 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY SPLINTS 2021−2027 (%)

TABLE 106 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY SYNTHETIC SPLINTS & CASTS 2021−2027 ($ MILLION)

TABLE 107 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY SYNTHETIC SPLINTS & CASTS 2021−2027 (%)

TABLE 108 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY PLASTER OF PARIS SPLINTS & CASTS 2021−2027 ($ MILLION)

TABLE 109 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY PLASTER OF PARIS SPLINTS & CASTS 2021−2027 (%)

TABLE 110 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY UPPER BODY 2021−2027 ($ MILLION)

TABLE 111 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY UPPER BODY 2021−2027 (%)

TABLE 112 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY LOWER BODY 2021−2027 ($ MILLION)

TABLE 113 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY LOWER BODY 2021−2027 (%)

TABLE 114 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY ORTHOTIC & ORTHOPEDIC CLINICS 2021−2027 ($ MILLION)

TABLE 115 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY ORTHOTIC & ORTHOPEDIC CLINICS 2021−2027 (%)

TABLE 116 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY HOSPITALS 2021−2027 ($ MILLION)

TABLE 117 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY HOSPITALS 2021−2027 (%)

TABLE 118 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY OTHERS 2021−2027 ($ MILLION)

TABLE 119 GLOBAL ORTHOPEDIC SPLINTS & CASTS MARKET BY OTHERS 2021−2027 (%)

Select a license type that suits your business needs

single-user Single User Licence
$4200.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4999.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5999.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$2000.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Interested in data center portfolio for this report?
Click here

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date